Jon Alexander Schwartz
Chief Tech/Sci/R&D Officer at Nanospectra Biosciences, Inc.
Profile
Jon Alexander Schwartz is currently the Director-Clinical Research at Nanospectra Biosciences, Inc. He has an undergraduate and graduate degree from Rice University and a doctorate from the University of Texas Graduate School of Biomedical Sciences.
Jon Alexander Schwartz active positions
| Companies | Position | Start |
|---|---|---|
Nanospectra Biosciences, Inc.
 Nanospectra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Nanospectra Biosciences, Inc. provides commercializing particle-based therapies the selective and precise thermal destruction of solid tumors. It develops AuroLase Therapy utilizing AuroShell Particles (also referred to as nanoshells) for the precise, particle-based thermal ablation of solid tumors. The company was founded by Naomi J. Halas, Jennifer L. West, and Daniel M. Watkins in 2002 and is headquartered in Houston, TX. | Chief Tech/Sci/R&D Officer | 2013-06-12 |
Training of Jon Alexander Schwartz
| Rice University | Graduate Degree |
| University of Texas Graduate School of Biomedical Sciences | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Nanospectra Biosciences, Inc.
Nanospectra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Nanospectra Biosciences, Inc. provides commercializing particle-based therapies the selective and precise thermal destruction of solid tumors. It develops AuroLase Therapy utilizing AuroShell Particles (also referred to as nanoshells) for the precise, particle-based thermal ablation of solid tumors. The company was founded by Naomi J. Halas, Jennifer L. West, and Daniel M. Watkins in 2002 and is headquartered in Houston, TX. | Health Technology |
- Stock Market
- Insiders
- Jon Alexander Schwartz
